Summary

Novo Nordisk, a company dedicated to addressing chronic diseases like diabetes and obesity for over a century, is expanding its capabilities in Emerging Technologies (ET) within Chemical API development and production. The new Petersburg, Virginia site aims to strengthen and accelerate their Small M...